Scientists continue studying how hemp-derived cannabinoids may work together to support healthy inflammatory responses within the body. In the review “Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices,” researchers examined how cannabinoids such as CBD, CBG, CBC, and other naturally occurring hemp compounds interact when combined in full-spectrum Cannabis sativa extracts. The review focused on how cannabinoids may work synergistically with terpenes, flavonoids, and other plant compounds to influence inflammation and immune signaling pathways.

The research highlighted growing evidence supporting what is commonly known as the “entourage effect,” where cannabinoids and other hemp compounds may produce different biological responses when used together rather than in isolation. Researchers reviewed studies showing that full-spectrum cannabinoid formulations demonstrated anti-inflammatory, antioxidant, and immune-modulating activity across multiple laboratory and preclinical models. These effects were linked to interactions with CB1, CB2, TRPV1, PPARγ, and other receptors involved in inflammatory balance and cellular signaling.

The review also discussed how combining cannabinoids with natural Cannabis sativa plant matrices may improve bioavailability and broaden biological activity compared to isolated cannabinoids alone. While additional human clinical studies are still needed, research like this continues expanding scientific understanding of how broad-spectrum and full-spectrum hemp formulations may support overall wellness, recovery, and healthy inflammatory response pathways throughout the body.

Source

Pagano C, Navarra G, Coppola L, et al. Phytocannabinoids as anti-inflammatory agents: Synergistic effects when combined with Cannabis sativa L. matrices. Published March 2025. https://pubmed.ncbi.nlm.nih.gov/41478536/